The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial

Jenny Sadler Gallagher, Henry A Feldman, Natalie A Stokes, Marc R Laufer, Mark D Hornstein, Catherine M Gordon, Amy D DiVasta
Journal of pediatric and adolescent gynecology · 2016 · vol. 30(2) , pp. 215–222 · doi:10.1016/j.jpag.2016.02.008 · PMID:26927501 · W2284702379
article OA: green CC0 ⤵ 40 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This randomized controlled trial investigated the effects of gonadotropin-releasing hormone agonist combined with add-back therapy on quality of life in adolescents with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Endometriosis Gonadotropin-Releasing Hormone Leuprolide Norethindrone Quality of Life Adolescent Boston Contraceptives, Oral, Synthetic Contraceptives, Oral, Synthetic Double-Blind Method Drug Therapy, Combination Endometriosis Endometriosis Endometriosis Estrogens Estrogens Estrogens, Conjugated (USP) Estrogens, Conjugated (USP) Female Gonadotropin-Releasing Hormone

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (16)

Cited by (40)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:21:13.485820+00:00
License: CC0 · commercial use OK